Literature DB >> 25395397

Cost-related barriers to use of health services and prescription medicines in Finland: a cross-sectional survey.

Katri Aaltonen1, Jani Miettinen2, Ilpo Airio2, Jaana E Martikainen2, Leena K Saastamoinen2, J Simon Bell3, Sirpa Hartikainen4, Pauline Norris5.   

Abstract

BACKGROUND: The objective was to examine cost-related barriers to using health services and prescription medicines in Finland.
METHODS: A survey that examined adults' experiences of and opinions about the social security system was mailed to a random population-based sample of 5000 Finns aged 18-74 years. The survey assessed households' cost-related barriers to use of health services, prescription medicines and social assistance in the past year. The responses were adjusted for sociodemographic and health predictors by weighting and logistic regression.
RESULTS: Responses were received from 1770 households. In total, 18% had experienced at least one cost-related barrier; 11% did not fill a prescription, 8% did not go to hospital and 13% went without another form of treatment. Of respondents diagnosed with a disabling illness or impairment, 32% reported at least one cost-related barrier. Households with below-average income reported barriers twice as often as above-average income households, after adjusting for age and health. Lower income [lowest tertile, odds ratio (OR) 5.0 compared with highest tertile], fair/poor self-assessed health (fair/poor OR 7.1 compared with very good/good), younger age (18-34 years OR 3.8 compared with 65-74 years), lower education (primary OR 1.6 compared with tertiary) and female gender (OR 1.4) were significantly associated with more frequent cost-related barriers. Overall, 34% of households who encountered cost-related barriers had applied for and 17% had received social assistance.
CONCLUSIONS: Cost-related barriers were common among respondents with low income and/or poor health. These barriers may thus have a role in creating inequities in access to health care in Finland.
© The Author 2014. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25395397     DOI: 10.1093/eurpub/cku176

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  7 in total

1.  The Patient Protection and Affordable Care Act and Utilization of Preventive Health Care Services Among Asian Americans in Michigan during Pre- and Post-Affordable Care Act Implementation.

Authors:  Tsu-Yin Wu; Vedhika Raghunathan
Journal:  J Community Health       Date:  2019-08

2.  Income differences in the type of antihypertensive medicines used in ambulatory settings in Finland: a register-based study.

Authors:  Härkönen Mirva; Timonen Johanna; Tervola Jussi; Katri Aaltonen
Journal:  Eur J Clin Pharmacol       Date:  2015-07-31       Impact factor: 2.953

3.  Trajectories of Antidepressant Medication before and after the Onset of Unemployment by Subsequent Employment Experience.

Authors:  Taina Leinonen; Netta Mäki; Pekka Martikainen
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

4.  The effect of pharmaceutical co-payment increase on the use of social assistance-A natural experiment study.

Authors:  Hanna Rättö; Katri Aaltonen
Journal:  PLoS One       Date:  2021-05-05       Impact factor: 3.240

5.  Perspectives of stakeholders of the free maternity services for mothers in western Kenya: lessons for universal health coverage.

Authors:  Beverly Marion Ochieng; Margaret Kaseje; Dan Clement Owino Kaseje; Kevin Oria; Monica Magadi
Journal:  BMC Health Serv Res       Date:  2022-02-19       Impact factor: 2.655

6.  Health system strategies to increase HIV screening among pregnant women in Mesoamerica.

Authors:  Charbel El Bcheraoui; Paola Zúñiga-Brenes; Diego Ríos-Zertuche; Erin B Palmisano; Claire R McNellan; Sima S Desai; Marielle C Gagnier; Annie Haakenstad; Casey Johanns; Alexandra Schaefer; Bernardo Hernandez; Emma Iriarte; Ali H Mokdad
Journal:  Popul Health Metr       Date:  2018-03-20

7.  The effects of reimbursement reform of antidiabetic medicines from the patients' perspective - a survey among patients with type 2 diabetes in Finland.

Authors:  Taika Suviranta; Johanna Timonen; Janne Martikainen; Emma Aarnio
Journal:  BMC Health Serv Res       Date:  2019-10-29       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.